---
title: "Zoetis Shares Plunge 12.8% As FY26 Outlook Slashed; Q1 EPS Rises"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285545972.md"
description: "Zoetis, Inc. (ZTS) shares fell 12.8% after the company revised its fiscal 2026 outlook, projecting earnings between $6.35 and $6.50 per share, down from previous estimates. Despite a slight increase in Q1 net income to $601 million ($1.42 per share), adjusted earnings rose to $1.53 per share. Revenue for the quarter increased 3% to $2.26 billion, but organic revenue growth was flat. The stock is currently trading at $96.99, reflecting a significant drop in pre-market trading."
datetime: "2026-05-07T11:57:26.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285545972.md)
  - [en](https://longbridge.com/en/news/285545972.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285545972.md)
---

# Zoetis Shares Plunge 12.8% As FY26 Outlook Slashed; Q1 EPS Rises

Add  as your preferred news source on Google

 Add Now

While reporting financial results for the first quarter on Thursday, animal health company Zoetis, Inc. (ZTS) raised its earnings, adjusted earnings and revenue guidance for the full year 2026, based on the current operating environment.

For fiscal 2026, the company now projects earnings in a range of $6.35 to $6.50 per share and adjusted earnings in the range of $6.85 to $7.00 per share on revenues between $9.68 billion and $9.96 billion, with organic operational revenue growth of 2 to 5 percent.

Previously, the company expected adjusted earnings in the range of $7.00 to $7.10 per share on revenues between $9.825 billion and $10.025 billion.

For the first quarter, the company reported net income attributable to Zoetis of $601 million or $1.42 per share, compared to $602 million or $1.34 per share in the prior-year quarter.

Excluding items, adjusted earnings for the quarter were $1.53 per share, compared to $1.41 per share in the year-ago quarter.

Revenue for the quarter grew 3 percent to $2.26 billion from $2.20 billion in the same quarter last year. On an organic operational basis, revenues remain flat, excluding the impact of foreign currency and divestitures.

In Thursday's pre-market trading, ZTS is trading on the NYSE at $96.99, down $14.18 or 12.76 percent.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com

For comments and feedback contact: editorial@rttnews.com

Business News

### Related Stocks

- [ZTS.US](https://longbridge.com/en/quote/ZTS.US.md)
- [PAWZ.US](https://longbridge.com/en/quote/PAWZ.US.md)

## Related News & Research

- [Securities Fraud Investigation Into Zoetis Inc. (ZTS) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz](https://longbridge.com/en/news/286616590.md)
- [Major Purchase Alert: MICHAEL MCCALLISTER Invests $233K In Zoetis Stock](https://longbridge.com/en/news/286283898.md)
- [Zoetis Inc. (ZTS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation](https://longbridge.com/en/news/286800814.md)
- [Zoetis (ZTS) Valuation Check After Rare Q1 2026 Miss And Cut To Full Year Guidance](https://longbridge.com/en/news/286140773.md)
- [Zoetis Stock: Analyst Estimates & Ratings](https://longbridge.com/en/news/285962446.md)